Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

A novel lung injury animal model using KL-6-measurable human MUC1-expressing mice.

Sakai M, Kubota T, Ohnishi H, Yokoyama A.

Biochem Biophys Res Commun. 2013 Mar 15;432(3):460-5. doi: 10.1016/j.bbrc.2013.01.123. Epub 2013 Feb 11.

PMID:
23410752
2.

KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia.

Daimon T, Tajima S, Oshikawa K, Bando M, Ohno S, Sugiyama Y.

Intern Med. 2005 Aug;44(8):811-7.

3.

KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Kunitake R, Kuwano K, Yoshida K, Maeyama T, Kawasaki M, Hagimoto N, Hara N.

Respiration. 2001;68(5):488-95.

PMID:
11694811
4.
5.

Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.

Xu L, Yang D, Zhu S, Gu J, Ding F, Bian W, Rong Z, Shen C.

Exp Lung Res. 2013 Aug;39(6):241-8. doi: 10.3109/01902148.2013.798056. Epub 2013 May 15.

PMID:
23672275
6.

Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis.

Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS.

Am J Respir Crit Care Med. 1997 Jul;156(1):109-15.

PMID:
9230733
7.

Changes in pulmonary tissue structure and KL-6/MUC1 expression in a newborn rat model of hyperoxia-induced bronchopulmonary dysplasia.

Zhu Y, Fu J, You K, Jin L, Wang M, Lu D, Xue X.

Exp Lung Res. 2013 Dec;39(10):417-26. doi: 10.3109/01902148.2013.810795.

PMID:
24298937
8.

Lung surfactant protein D (SP-D) response and regulation during acute and chronic lung injury.

Gaunsbaek MQ, Rasmussen KJ, Beers MF, Atochina-Vasserman EN, Hansen S.

Lung. 2013 Jun;191(3):295-303. doi: 10.1007/s00408-013-9452-x. Epub 2013 Feb 24.

9.

Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome.

Nathani N, Perkins GD, Tunnicliffe W, Murphy N, Manji M, Thickett DR.

Crit Care. 2008;12(1):R12. doi: 10.1186/cc6785. Epub 2008 Jan 23.

10.

KL4-surfactant prevents hyperoxic and LPS-induced lung injury in mice.

Kinniry P, Pick J, Stephens S, Jain D, Solomides CC, Niven R, Segal R, Christofidou-Solomidou M.

Pediatr Pulmonol. 2006 Oct;41(10):916-28.

PMID:
16871629
11.

KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.

Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, Yokoyama A, Hamada H, Fujioka S, Hiwada K.

Am Rev Respir Dis. 1993 Sep;148(3):637-42.

PMID:
8368634
12.

Serum SP-D is a marker of lung injury in rats.

Pan T, Nielsen LD, Allen MJ, Shannon KM, Shannon JM, Selman M, Mason RJ.

Am J Physiol Lung Cell Mol Physiol. 2002 Apr;282(4):L824-32.

13.

Effects of molecular structural variants on serum Krebs von den Lungen-6 levels in sarcoidosis.

Shigemura M, Nasuhara Y, Konno S, Shimizu C, Matsuno K, Yamguchi E, Nishimura M.

J Transl Med. 2012 Jul 11;10:111. doi: 10.1186/1479-5876-10-111.

14.

Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.

Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, Silver RM; Scleroderma Lung Study Research Group.

J Rheumatol. 2009 Apr;36(4):773-80. doi: 10.3899/jrheum.080633. Epub 2009 Mar 13.

PMID:
19286849
15.

[The effect of recombinant interleukin-10/Fc fusion protein on lipopolysaccharide-induced acute lung injury in mice].

Bi MH, Wang BE, Zheng XX, Li M, Mayer K, Zhang SW.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Aug;20(8):461-4. Chinese.

16.

Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.

Aono Y, Ledford JG, Mukherjee S, Ogawa H, Nishioka Y, Sone S, Beers MF, Noble PW, Wright JR.

Am J Respir Crit Care Med. 2012 Mar 1;185(5):525-36. doi: 10.1164/rccm.201103-0561OC. Epub 2011 Dec 28.

17.

[Alterations of SP-A, SP-D and KL-6 in serum and bronchoalveolar lavage fluid in children with Mycoplasma pneumoniae pneumonia].

Shu LH, Shang YX, Cai XX, Zong ZH, Meng XN, Zhang H, Wang ZJ, Dai B.

Zhonghua Er Ke Za Zhi. 2013 Oct;51(10):779-82. Chinese.

PMID:
24406233
18.

Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.

Kimura T, Nojiri T, Hosoda H, Shintani Y, Inoue M, Miyazato M, Okumura M, Kangawa K.

Eur J Cardiothorac Surg. 2015 Oct;48(4):e85-91. doi: 10.1093/ejcts/ezv261. Epub 2015 Jul 29.

PMID:
26224340
19.

[Effects of the treatment with different fluids on alveolar epithelium barrier in rats with acute lung injury].

Wei HX, Yang Y, Qiu HB, Guo T, Zhao MM, Chen QH.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009 Jul;21(7):412-5. Chinese.

20.

Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases.

Ishikawa N, Hattori N, Yokoyama A, Kohno N.

Respir Investig. 2012 Mar;50(1):3-13. doi: 10.1016/j.resinv.2012.02.001. Epub 2012 Mar 8. Review.

Items per page

Supplemental Content

Write to the Help Desk